Stockreport

FDA approves ARS' neffy 1mg for paediatric anaphylaxis [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF reactions including anaphylaxis in paediatric patients aged four years and above weighing between 15kg and 30kg. Neffy's needle-free administration allows for an insta [Read more]